Primary Site >> Biliary tract Cancer

Gene >> MYC

  • 1989
  • 1993
  • 1994
  • 1996
  • 2003
  • 2005
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Oncogene expression in cholangiocarcinoma and in normal hepatic development.
PMID: 2574140
Ref: Expression of oncogene products and growth factors in early gallbladder cancer, advanced gallbladder cancer, and chronic cholecystitis.
PMID: 8093356
Ref: [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].
PMID: 7732224
Ref: Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
PMID: 8916146
Ref: Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression.
PMID: 12532418
Ref: [The roles of VEGF and C-myc in occurrence, development and metastasis of gallbladder carcinoma].
PMID: 12744166
Ref: Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas.
PMID: 16142313
Ref: [Research on resveratrol's effects on suppressing growth and inducing apoptosis of GBC cells].
PMID: 16209266
Ref: Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R.
PMID: 17369680
Ref: FBXW7/hCDC4 is a general tumor suppressor in human cancer.
PMID: 17909001
Ref: Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
PMID: 17919228
Ref: Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.
PMID: 18306229
Ref: Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater.
PMID: 18936968
Ref: Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma.
PMID: 19331129
Ref: Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
PMID: 21160963
Ref: Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro.
PMID: 19954766
Ref: The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells.
PMID: 20101459
Ref: Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
PMID: 21325634
Ref: Down-regulation of c-Myc expression inhibits the invasion of bile duct carcinoma cells.
PMID: 21557726
Ref: MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin.
PMID: 22484120
Ref: Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.
PMID: 22819820
Ref: TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitro.
PMID: 23480758
Ref: Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
PMID: 23134201
Ref: Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling.
PMID: 23646150
Ref: Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
PMID: 23799613
Ref: The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with beta-catenin.
PMID: 24888903
Ref: Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer.
PMID: 24953832
Ref: Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.
PMID: 25691459
Ref: Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
PMID: 26287365
Ref: Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer.
PMID: 26460616
Ref: LTbetaR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.
PMID: 26206664
Ref: SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
PMID: 26563145
Ref: Deregulated methionine adenosyltransferase alpha1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(double dagger).
PMID: 26969892
Ref: Characterizing the activation of the Wnt signaling pathway in hilar cholangiocarcinoma using a tissue microarray approach.
PMID: 26972709
Ref: New molecular interactions of c-Myc in cholangiocarcinoma may open new therapeutic opportunities.
PMID: 27102840
Ref: Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
PMID: 27981602
Ref: E3 ubiquitin ligase FBW7alpha inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
PMID: 28184929
Ref: Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
PMID: 28535506
Ref: The PLGF/c-MYC/miR-19a axis promotes metastasis and stemness in gallbladder cancer.
PMID: 29575299
Ref: Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
PMID: 29733835
Ref: Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.
PMID: 30156013
Ref: Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
PMID: 30205958
Ref: miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma.
PMID: 30235453